147.78
1.24%
+1.81
Overview
News
Price History
Option Chain
Why CLX Down?
Discussions
Forecast
Stock Split
Dividend History
Clorox Co. stock is currently priced at $147.78, with a 24-hour trading volume of 1.05M.
It has seen a +1.24% increased in the last 24 hours and a -1.97% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $145.6 pivot point. If it approaches the $148.0 resistance level, significant changes may occur.
Previous Close:
$145.97
Open:
$145.28
24h Volume:
1.05M
Market Cap:
$18.34B
Revenue:
$7.31B
Net Income/Loss:
$80.00M
P/E Ratio:
217.32
EPS:
0.68
Net Cash Flow:
$728.00M
1W Performance:
+3.82%
1M Performance:
-1.97%
6M Performance:
+21.51%
1Y Performance:
-10.56%
Clorox Co. Stock (CLX) Company Profile
Name
Clorox Co.
Sector
Industry
Phone
510-271-7000
Address
1221 Broadway, Oakland, CA
Clorox Co. Stock (CLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-05-24 | Downgrade | DA Davidson | Buy → Neutral |
Dec-15-23 | Upgrade | BofA Securities | Underperform → Neutral |
Nov-22-23 | Upgrade | JP Morgan | Underweight → Neutral |
Nov-13-23 | Initiated | Jefferies | Underperform |
Nov-06-23 | Upgrade | UBS | Sell → Neutral |
Nov-02-23 | Upgrade | Citigroup | Neutral → Buy |
Oct-12-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
Oct-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
Oct-02-23 | Upgrade | DA Davidson | Neutral → Buy |
Sep-22-23 | Initiated | HSBC Securities | Hold |
Aug-03-23 | Upgrade | Atlantic Equities | Underweight → Neutral |
Feb-17-23 | Initiated | Citigroup | Neutral |
Oct-18-22 | Initiated | Evercore ISI | Underperform |
Oct-17-22 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Sep-14-22 | Resumed | BofA Securities | Underperform |
Jul-13-22 | Initiated | Raymond James | Outperform |
Feb-04-22 | Downgrade | Atlantic Equities | Neutral → Underweight |
Feb-04-22 | Reiterated | Deutsche Bank | Hold |
Feb-04-22 | Reiterated | JP Morgan | Underweight |
Feb-04-22 | Reiterated | Morgan Stanley | Underweight |
Feb-04-22 | Reiterated | UBS | Sell |
Feb-04-22 | Reiterated | Wells Fargo | Underweight |
Feb-02-22 | Downgrade | Bernstein | Mkt Perform → Underperform |
Jan-26-22 | Downgrade | Credit Suisse | Neutral → Underperform |
Nov-02-21 | Reiterated | DA Davidson | Neutral |
Nov-02-21 | Reiterated | Deutsche Bank | Hold |
Nov-02-21 | Downgrade | JP Morgan | Neutral → Underweight |
Nov-02-21 | Reiterated | Wells Fargo | Underweight |
Sep-03-21 | Downgrade | Argus | Buy → Hold |
Aug-04-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
Aug-04-21 | Reiterated | Citigroup | Buy |
Aug-04-21 | Reiterated | Credit Suisse | Neutral |
Aug-04-21 | Reiterated | Deutsche Bank | Hold |
Aug-04-21 | Reiterated | Morgan Stanley | Underweight |
Aug-04-21 | Reiterated | RBC Capital Mkts | Sector Perform |
Aug-04-21 | Reiterated | UBS | Sell |
Aug-04-21 | Reiterated | Wells Fargo | Underweight |
Jun-24-21 | Initiated | UBS | Sell |
May-03-21 | Downgrade | Wells Fargo | Overweight → Underweight |
Mar-18-21 | Downgrade | DA Davidson | Buy → Neutral |
Feb-19-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
Jan-20-21 | Initiated | Bernstein | Mkt Perform |
Dec-14-20 | Upgrade | Citigroup | Neutral → Buy |
Dec-08-20 | Initiated | Wells Fargo | Overweight |
Oct-16-20 | Downgrade | JP Morgan | Overweight → Neutral |
Jun-30-20 | Initiated | DA Davidson | Buy |
Mar-19-20 | Downgrade | Credit Suisse | Outperform → Neutral |
Mar-16-20 | Upgrade | JP Morgan | Underweight → Overweight |
Mar-09-20 | Upgrade | Argus | Hold → Buy |
Oct-03-19 | Reiterated | BofA/Merrill | Neutral |
Sep-23-19 | Downgrade | Barclays | Equal Weight → Underweight |
May-20-19 | Downgrade | Argus | Buy → Hold |
May-02-19 | Reiterated | BofA/Merrill | Neutral |
May-02-19 | Upgrade | Deutsche Bank | Sell → Hold |
Apr-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
Mar-07-19 | Initiated | Credit Suisse | Outperform |
Dec-06-18 | Reiterated | BofA/Merrill | Neutral |
Sep-25-18 | Upgrade | Argus | Hold → Buy |
Jul-18-18 | Downgrade | Goldman | Neutral → Sell |
Apr-19-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Feb-08-18 | Downgrade | Argus | Buy → Hold |
Jan-04-18 | Upgrade | BofA/Merrill | Underperform → Neutral |
View All
Clorox Co. Stock (CLX) Latest News
Earnings Preview: Clorox (CLX) Q3 Earnings Expected to Decline
Zacks Investment Research
Procter & Gamble (PG) Q3 Earnings Beat Estimates
Zacks Investment Research
Decoding 9 Analyst Evaluations For Clorox
Benzinga
Zacks Industry Outlook Highlights Colgate-Palmolive, Henkel, Church & Dwight and The Clorox
Zacks Investment Research
4 Soap & Cleaning Materials Stocks to Watch Amid Favorable Industry Trends
Zacks Investment Research
2 High-Yield Dividend Stocks Billionaires Are Buying Hand Over Fist
The Motley Fool
Clorox Co. Stock (CLX) Financials Data
Clorox Co. (CLX) Revenue 2024
CLX reported a revenue (TTM) of $7.31 billion for the quarter ending December 31, 2023, a +3.47% rise year-over-year.
Clorox Co. (CLX) Net Income 2024
CLX net income (TTM) was $80.00 million for the quarter ending December 31, 2023, a -81.61% decrease year-over-year.
Clorox Co. (CLX) Cash Flow 2024
CLX recorded a free cash flow (TTM) of $728.00 million for the quarter ending December 31, 2023, a +0.97% increase year-over-year.
Clorox Co. (CLX) Earnings per Share 2024
CLX earnings per share (TTM) was $0.63 for the quarter ending December 31, 2023, a -82.00% decline year-over-year.
Clorox Co. Stock (CLX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Jacobsen Kevin B | EVP - Chief Financial Officer |
Aug 14 '23 |
Sale |
160.82 |
3,346 |
538,096 |
23,224 |
About Clorox Co.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands. It also provides charcoal products under the Kingsford and Match Light brands; bags, wraps, and containers under the Glad brand; cat litter products under the Fresh Step, Scoop Away, and Ever Clean brands; and digestive health products under the RenewLife brand. In addition, the company offers dressings and sauces primarily under the Hidden Valley, KC Masterpiece, Kingsford, and Soy Vay brands; water-filtration systems and filters under the Brita brand; natural personal care products under the Burt's Bees brand; and dietary supplements under the Rainbow Light, Natural Vitality, and Neocell brands. Further, it markets its products under the PinoLuz, Ayudin, Limpido, Clorinda, Poett, Mistolin, Lestoil, Bon Bril, Agua Jane, and Chux brands. The company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force and medical supply distributors. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.
Cap:
|
Volume (24h):